Laura Tham

Keyphrases

1. Core Outcome Set 100%
2. Randomized Controlled Trial 66%
3. Preterm Birth 62%
4. Clinical Trials 48%
5. Ado-trastuzumab 33%
6. T-DM1 33%
7. Pulmonary Medicine 33%
8. Preterm Birth Prevention 33%
9. Respiratory Medicine 33%
10. Reporting Guidelines 33%
11. Risk Outcomes 33%
12. Patient Outcomes 33%
13. Risk-benefit 33%
14. Trial Registration 33%
15. Patient Benefit 33%
16. Drug Development 33%
17. Sectional Analysis 33%
18. Patient Risk 33%
19. Clinical Trial Registry 29%
20. Inclusion Criteria 18%
21. Intervention Effectiveness 14%
22. Adverse Events 13%
23. FDA-approved Drugs 13%
24. Objective Response Rate 13%
25. Trialists 10%
26. PRISMA 8%
27. Trial Adherence 8%
28. Equator 8%
29. PRISMA-P 8%
30. EQUATOR Network 8%
31. Instructions to Authors 8%
32. CHEERS 8%
33. Top 100 8%
34. Offspring Mortality 7%
35. Neonatal Brain Development 7%
36. Zero Outcomes 7%
37. Extracted Data 7%
38. Trial Registries 7%
39. International Clinical Trials Registry Platform (ICTRP) 7%
40. Research Quality 7%
41. Outcome Reporting 7%
42. Trastuzumab Emtansine 6%
43. Clinical Testing 6%
44. Treatment Burden 6%
45. Clinical Outcomes 6%
46. Trial Characteristics 6%
47. Institutional Review Board 6%
48. Drug Efficacy 6%
49. Median Progression-free Survival 6%
50. Survival Response 6%